HARROW, INC. (HROW) Most Active Options

The 25 most actively traded HARROW, INC. (HROW) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Oct 9, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$29.45
52-week range
$29.16 – $54.30
ATM IV (30d)
98.5%
IV rank
43 / 100
Moderate
Expected move
±$4.02 (±13.6%)
Put/call OI
0.11
Call-heavy
Max pain
$30
↑ 1.9% above close
Next earnings
Nov 11, 2026

Chat with OptAI about HROW


Most Active HROW Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
HROW $50 call Dec 17, 2027 434d $3.88 68.2% 16 0.41 1,355 151 6.1× avg
HROW $30 call Oct 16, 2026 7d $0.65 0.0% 0 1.00 263 114 3.0× avg
HROW $35 call Nov 20, 2026 42d $1.67 74.2% 48 0.35 167 101 17.3× avg
HROW $40 call Nov 20, 2026 42d $1.02 72.7% 27 0.18 6 75 63.6× avg
HROW $30 put Oct 16, 2026 7d $1.05 93.6% 57 -0.40 285 46 2.6× avg
HROW $32 call Dec 18, 2026 70d $2.01 57.7% 25 0.50 1 30 3.1× avg
HROW $31 call Dec 18, 2026 70d $2.35 54.0% 17 0.54 0 30 3.1× avg
HROW $40 call Dec 17, 2027 434d $5.90 67.6% 26 0.53 1,583 27 1.8× avg
HROW $25 put Dec 17, 2027 434d $4.90 66.8% 38 -0.24 0 25 38.2× avg
HROW $28 put Nov 20, 2026 42d $2.00 79.6% 81 -0.31 6 24 17.0× avg
HROW $47 call Jan 15, 2027 98d $0.95 86.0% 37 0.24 2,649 20 0.8× avg
HROW $55 call Dec 17, 2027 434d $3.60 59.4% 5 0.31 59 15 0.6× avg
HROW $30 put Nov 20, 2026 42d $2.85 87.8% 100 -0.40 95 15 8.2× avg
HROW $33 call Oct 16, 2026 7d $0.05 77.7% 0 0.27 164 14 6.2× avg
HROW $35 call Dec 17, 2027 434d $6.90 59.2% 16 0.58 64 14 3.0× avg
HROW $25 put Jan 15, 2027 98d $1.80 72.6% 55 -0.22 144 11 16.8× avg
HROW $25 put Nov 20, 2026 42d $0.89 74.0% 35 -0.17 3 10 41.4× avg
HROW $35 call Dec 18, 2026 70d $1.60 67.2% 32 0.39 16 10 1.7× avg
HROW $33 call Dec 17, 2027 434d $6.64 55.2% 5 0.60 21 10 2.1× avg
HROW $45 call Dec 17, 2027 434d $4.80 65.7% 12 0.46 31 7 0.3× avg
HROW $50 call Apr 16, 2027 189d $1.40 67.3% 14 0.24 139 6 0.2× avg
HROW $28 put Dec 18, 2026 70d $2.55 77.1% 75 -0.32 10 6 4.3× avg
HROW $30 call Dec 17, 2027 434d $8.50 57.0% 12 0.67 118 6 0.6× avg
HROW $30 call Nov 20, 2026 42d $2.75 49.2% 22 0.60 61 5 6.3× avg
HROW $20 call Dec 17, 2027 434d $13.58 59.4% 47 0.86 43 4 2.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active HROW contract today is the $50 call expiring in 434 days, with 151 contracts traded. Calls dominate the most-active list (18 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on HROW for free

Build multi-leg HROW strategies, visualize payoffs, and scan the full US options universe with OptiView.

HROW Options FAQ

Which HROW option contract is most active today?

The most traded HROW contract is the $50 call expiring Dec 17, 2027, with 151 contracts traded as of Oct 9, 2026.

How does OptiView rank the most active HROW options?

The table lists the 25 HROW contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.